A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma.

Qing, Shuiwang; Gu, Lei; Du, Tingting; Yin, Xiaolan; Zhang, Ke-Jia; Zhang, Huo-Jun

Qing, Shuiwang; Gu, Lei; Du, Tingting; Yin, Xiaolan; Zhang, Ke-Jia; Zhang, Huo-Jun.

Afiliação

Qing S; Department of Radiation Oncology, Changhai Hospital of Naval Military Medical University, Shanghai, China.
Gu L; Department of Radiation Oncology, Changhai Hospital of Naval Military Medical University, Shanghai, China.
Du T; Department of Special Clinic, Changhai Hospital of Naval Military Medical University, Shanghai, China.
Yin X; Department of Radiation Oncology, Changhai Hospital of Naval Military Medical University, Shanghai, China.
Zhang KJ; Clinical Medicine, Medical College of Nantong University, Nantong, China.
Zhang HJ; Present address: Department of Urology, Shanghai East Hospital, Tongji University, Shanghai, China.

Technol Cancer Res Treat ; 22: 15330338231202893, 2023.

Article em En | MEDLINE | ID: mdl-37750231

Assuntos

Adenocarcinoma; Segunda Neoplasia Primária; Neoplasias Retais; Humanos; Antígeno Carcinoembrionário; Resultado do Tratamento; Estudos Retrospectivos; Neoplasias Retais/terapia; Neoplasias Retais/patologia; Biomarcadores Tumorais; Quimiorradioterapia Adjuvante; Quimiorradioterapia; Terapia Neoadjuvante; Adenocarcinoma/terapia; Adenocarcinoma/patologia

Palavras-chave

pCR; predictive model; preoperative chemo-radiotherapy; rectal cancer; ultra-low rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Adenocarcinoma / Segunda Neoplasia Primária Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google